{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:42:30Z","timestamp":1790883750265,"version":"4.1.0"},"reference-count":43,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["299309"],"award-info":[{"award-number":["299309"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The human small intestine can be involved in the first-pass metabolism of drugs. Under this condition, members of the CYP450 superfamily are expected to contribute to drug presystemic biotransformation. The aim of this study was to quantify protein expression levels of 16 major CYP450 isoforms in tissue obtained from nine human organ donors in seven subsections of the small intestine, i.e., duodenum (one section, N = 7 tissue samples), jejunum (three subsections (proximal, mid and distal), N = 9 tissue samples) and ileum (three subsections, (proximal, mid and distal), N = 9 tissue samples), using liquid chromatography tandem mass spectrometry (LC-MS\/MS) based targeted proteomics. CYP450 absolute protein expression levels were compared to mRNA levels and enzyme activities by using established probe drugs. Proteins corresponding to seven of sixteen potential CYP450 isoforms were detected and quantified in various sections of the small intestine: CYP2C9, CYP2C19, CYP2D6, CYP2J2, CYP3A4, CYP3A5 and CYP4F2. Wide inter-subject variability was observed, especially for CYP2D6. CYP2C9 (p = 0.004) and CYP2C19 (p = 0.005) expression levels decreased along the small intestine. From the duodenum to the ileum, CYP2J2 (p = 0.001) increased, and a trend was observed for CYP3A5 (p = 0.13). CYP3A4 expression was higher in the jejunum than in the ileum (p = 0.03), while CYP4F2 expression was lower in the duodenum compared to the jejunum and the ileum (p = 0.005). CYP450 protein levels were better correlated with specific isoform activities than with mRNA levels. This study provides new data on absolute CYP450 quantification in human small intestine that could improve physiologically based pharmacokinetic models. These data could better inform drug absorption profiles while considering the regional expression of CYP450 isoforms.<\/jats:p>","DOI":"10.3390\/ijms222312791","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"12791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Determination of CYP450 Expression Levels in the Human Small Intestine by Mass Spectrometry-Based Targeted Proteomics"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6240-6693","authenticated-orcid":false,"given":"Alexia","family":"Grangeon","sequence":"first","affiliation":[{"name":"CRCHUM, Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, 900 St. Denis Street, Montreal, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Clermont","sequence":"additional","affiliation":[{"name":"CRCHUM, Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, 900 St. Denis Street, Montreal, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azemi","family":"Barama","sequence":"additional","affiliation":[{"name":"CHUM, Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, 1000 St. Denis Street, Montreal, QC H2X 0C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Gaudette","sequence":"additional","affiliation":[{"name":"CRCHUM, Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, 900 St. Denis Street, Montreal, QC H2X 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-9280","authenticated-orcid":false,"given":"Jacques","family":"Turgeon","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, 2940 Chemin de la Polytechnique, Montreal, QC H3T 1J4, Canada"},{"name":"Precision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, 13485 Veterans Way, Orlando, FL 32827, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-6447","authenticated-orcid":false,"given":"Veronique","family":"Michaud","sequence":"additional","affiliation":[{"name":"CRCHUM, Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al, 900 St. Denis Street, Montreal, QC H2X 0A9, Canada"},{"name":"Faculty of Pharmacy, Universit\u00e9 de Montr\u00e9al, 2940 Chemin de la Polytechnique, Montreal, QC H3T 1J4, Canada"},{"name":"Precision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, 13485 Veterans Way, Orlando, FL 32827, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.18.1","article-title":"Intestinal Absorption of Drugs Mediated by Drug Transporters: Mechanisms and Regulation","volume":"18","author":"Katsura","year":"2003","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","article-title":"Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts","volume":"43","author":"Ding","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1124\/dmd.105.008672","article-title":"The human intestinal cytochrome P450 \u201cpie\u201d","volume":"34","author":"Paine","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical Space for Optimum Oral Bioavailability: Contribution of Human Intestinal Absorption and First-Pass Elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1124\/dmd.114.058040","article-title":"The Revised Human Liver Cytochrome P450 \u201cPie\u201d: Absolute Protein Quantification of CYP4F and CYP3A Enzymes Using Targeted Quantitative Proteomics","volume":"42","author":"Michaels","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"ref_6","unstructured":"De Montellano, O.R.O. (2005). Cytochrome P450: Structure, Mechanism, and Biochemistry, Kluwer Academic\/Plenum Publishers."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2014.08.004","article-title":"Pre-systemic metabolism of orally administered drugs and strategies to overcome it","volume":"192","year":"2014","journal-title":"J. Control. Release"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-409X(97)00039-2","article-title":"Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction","volume":"27","author":"Thummel","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1006469621561","article-title":"The oral route for the administration of cytotoxic drugs: Strategies to increase the efficiency and consistency of drug delivery","volume":"18","author":"Bardelmeijer","year":"2000","journal-title":"Investig. New Drugs"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/17425255.2.4.591","article-title":"The road map to oral bioavailability: An industrial perspective","volume":"2","author":"Thomas","year":"2006","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00003088-200241040-00001","article-title":"The mucosa of the small intestine: How clinically relevant as an organ of drug metabolism?","volume":"41","author":"Doherty","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcp.2012.03.017","article-title":"Intestinal CYP3A4 and midazolam disposition in vivo associate with VDR polymorphisms and show seasonal variation","volume":"84","author":"Thirumaran","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsps.2012.03.005","article-title":"Loss of orally administered drugs in GI tract","volume":"20","author":"Gavhane","year":"2012","journal-title":"Saudi Pharm. J."},{"key":"ref_14","unstructured":"Waterbeemd, H.V.D., Lennernas, H., and Artursson, P. (2003). Application of the Biopharmaceutic Classification System Now and in the Future, in Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability, Wiley-VCH."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","article-title":"Drug-like properties and the causes of poor solubility and poor permeability","volume":"44","author":"Lipinski","year":"2000","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_16","first-page":"31087","article-title":"Oral Absorption, Intestinal Metabolism and Human Oral Bioavailability","volume":"10","author":"Varma","year":"2012","journal-title":"Top. Drug Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/bcp.13908","article-title":"Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine","volume":"85","author":"Clermont","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein Abundance of Clinically Relevant Drug-Metabolizing Enzymes in the Human Liver and Intestine: A Comparative Analysis in Paired Tissue Specimens","volume":"104","author":"Drozdzik","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_19","first-page":"1552","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2125.2005.02343.x","article-title":"Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein","volume":"59","author":"Pinto","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/jpet.106.106013","article-title":"Intestinal and Hepatic Metabolic Activity of Five Cytochrome P450 Enzymes: Impact on Prediction of First-Pass Metabolism","volume":"318","author":"Galetin","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/bcpt.13137","article-title":"Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis","volume":"124","author":"Fritz","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jpba.2018.04.003","article-title":"LC\u2013MS\/MS method for the simultaneous quantification of intestinal CYP and UGT activity","volume":"155","author":"Busch","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpba.2019.05.006","article-title":"Development and validation of an absolute protein assay for the simultaneous quantification of fourteen CYP450s in human microsomes by HPLC-MS\/MS-based targeted proteomics","volume":"173","author":"Grangeon","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1124\/dmd.119.089656","article-title":"Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine","volume":"48","author":"Couto","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jpba.2014.08.016","article-title":"Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics","volume":"100","author":"Busch","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1124\/dmd.111.042275","article-title":"Absolute Quantification and Differential Expression of Drug Transporters, Cytochrome P450 Enzymes, and UDP-Glucuronosyltransferases in Cultured Primary Human Hepatocytes","volume":"40","author":"Schaefer","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1124\/dmd.113.053801","article-title":"Targeted Precise Quantification of 12 Human Recombinant Uridine-Diphosphate Glucuronosyl Transferase 1A and 2B Isoforms Using Nano-Ultra-High-Performance Liquid Chromatography\/Tandem Mass Spectrometry with Selected Reaction Monitoring","volume":"41","author":"Fallon","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.116.072066","article-title":"Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics","volume":"44","author":"Prasad","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_31","unstructured":"U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), and Center for Veterinary Medicine (CVM) (2021, November 20). Bioanalytical Method Validation. Guidance for Industry, Available online: https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/dmd.117.078964","article-title":"Cytochrome P450 2J2: Potential Role in Drug Metabolism and Cardiotoxicity","volume":"46","author":"Solanki","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI113156","article-title":"Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man","volume":"80","author":"Watkins","year":"1987","journal-title":"J. Clin. Investig."},{"key":"ref_34","first-page":"387","article-title":"Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues","volume":"253","author":"Cugnenc","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_35","first-page":"804","article-title":"Characterization of human small intestinal cytochromes P-450","volume":"27","author":"Zhang","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1099-0461(1999)13:6<289::AID-JBT1>3.0.CO;2-N","article-title":"Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs","volume":"13","author":"Klose","year":"1999","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00008571-200309000-00005","article-title":"Differential expression and function of CYP2C isoforms in human intestine and liver","volume":"13","author":"Fromm","year":"2003","journal-title":"Pharmacogenetics"},{"key":"ref_38","first-page":"347","article-title":"Metabolic Characterization of the Major Human Small Intestinal Cytochrome P450s","volume":"29","author":"Obach","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/mol.109.054833","article-title":"CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant","volume":"75","author":"McDonald","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"25290","DOI":"10.1074\/jbc.M201466200","article-title":"Cytochrome P450 \u03c9-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status","volume":"277","author":"Sontag","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/dmd.111.042259","article-title":"Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities","volume":"40","author":"Ohtsuki","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Michaud, V., Frappier, M., Dumas, M.-C., and Turgeon, J. (2010). Metabolic Activity and mRNA Levels of Human Cardiac CYP450s Involved in Drug Metabolism. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0015666"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/rcm.3444","article-title":"mMass data miner: An open source alternative for mass spectrometric data analysis","volume":"22","author":"Strohalm","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:12Z","timestamp":1760168172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/23\/12791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":43,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["ijms222312791"],"URL":"https:\/\/doi.org\/10.3390\/ijms222312791","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}